GeoVax Partners With ABL to Advance cGMP Production of Vaccine Candidates

ABL, a subsidiary of Institut Mérieux, is a pure-play contract development and manufacturing organization (CDMO) specialized in development and manufacturing of gene therapies, oncolytic viruses and vaccine candidates.